Materials Today Bio, 2025 · DOI: https://doi.org/10.1016/j.mtbio.2025.101524 · Published: January 27, 2025
This study addresses the challenge of treating osteoporotic bone defects, which are often complicated by osteolysis (bone breakdown). The research team developed a 3D-printed scaffold infused with gallium to combat osteolysis and promote bone regeneration. The scaffold combines the osteogenic potential of mesoporous bioactive glass (MBG) and β-tricalcium phosphate (β-TCP) with the anti-bone resorption property of Ga doping. Different concentrations of Ga-MBG were incorporated into β-TCP to create composite scaffolds. The composite scaffolds were tested in vitro for cytocompatibility and their effects on osteoblast and osteoclast differentiation. The optimal concentration of Ga-MBG/TCP composite scaffold was then evaluated in a rat model of cranial defects associated with osteoporosis to assess its therapeutic efficacy and biological safety.
The Ga-MBG/TCP composite scaffold shows promise as a bone repair implant for treating osteoporotic bone defects.
The study identifies the optimal concentration of gallium ions (10 wt%) for balancing biological activity, bone regeneration, and osteolysis inhibition.
Further systematic investigations are necessary to evaluate the in vivo pharmacokinetics and long-term biosafety of these scaffolds.